Modified Posterior Scleral Reinforcement as a Treatment for High Myopia in Children and Its Therapeutic Effect
Joint Authors
Huang, Lvzhen
Miao, Zequn
Li, Luojia
Meng, Xiaoli
Guo, Lili
Cao, Di
Jia, Yanlei
He, Dongmei
Wang, Lejin
Source
Issue
Vol. 2019, Issue 2019 (31 Dec. 2019), pp.1-7, 7 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2019-01-22
Country of Publication
Egypt
No. of Pages
7
Main Subjects
Abstract EN
Purpose.
To investigate the safety and therapeutic effect of a modified posterior scleral reinforcement (PSR) in treating high myopia.
Methods.
A total of 85 highly myopic eyes in 47 children (6.3±3.6 years of age, range from 3 years to 15 years) who underwent this modified PSR were included in this study.
Axial length, refractive error, best-corrected visual acuity (BCVA), macular scans, and adverse events were recorded before the operation (as a baseline) and in postoperative reviews taken yearly for 5 years.
Results.
This was a 5-year research: 50% of the children (20 children, 40 eyes) participated in the 6-month review, 41% of the children (17 children, 33 eyes) participated in the 1-year review, 26% of the children (11 children, 21 eyes) participated in the 2-year review, 16% of the children (7 children, 13 eyes) participated in the 3-year review, 13% of the children (5.3 children, 11 eyes) participated in the 4-year review, and 8% of the children (3.3 children, 7 eyes) participated in the 5-year review.
Compared with the baseline, axial elongation was significantly changed (P<0.05) over the 5-year period in all of the children: 6-month (P=0.003), 1-year (P=0), 2-year (P=0), 3-year (P=0), 4-year (P=0), and 5-year (P=0).
The axial length was extended.
No significant difference was found in refractive error between measurements taken at baseline and at the 5-year postoperative visit in all of the children: 6-month (P=0.51), 1-year (P=0.50), 2-year (P=0.46), 3-year (P=0.56), 4-year (P=0.30), and 5-year (P=0.16).
There were significant differences in BCVA between measurements taken at baseline and at the postoperative 5-year visit in all the children: 6-month (P=0), 1-year (P=0), 2-year (P=0), 3-year (P=0), 4-year (P=0), and 5-year (P=0).
BCVA improved in 71 eyes (83.52%), remained stable in 14 eyes (16.47%), and declined in none of the children.
No serious adverse events occurred before the operation and during the 5-year follow-up period.
Conclusion.
This modified PSR could be a therapeutic treatment for high myopia.
American Psychological Association (APA)
Miao, Zequn& Li, Luojia& Meng, Xiaoli& Guo, Lili& Cao, Di& Jia, Yanlei…[et al.]. 2019. Modified Posterior Scleral Reinforcement as a Treatment for High Myopia in Children and Its Therapeutic Effect. BioMed Research International،Vol. 2019, no. 2019, pp.1-7.
https://search.emarefa.net/detail/BIM-1125872
Modern Language Association (MLA)
Miao, Zequn…[et al.]. Modified Posterior Scleral Reinforcement as a Treatment for High Myopia in Children and Its Therapeutic Effect. BioMed Research International No. 2019 (2019), pp.1-7.
https://search.emarefa.net/detail/BIM-1125872
American Medical Association (AMA)
Miao, Zequn& Li, Luojia& Meng, Xiaoli& Guo, Lili& Cao, Di& Jia, Yanlei…[et al.]. Modified Posterior Scleral Reinforcement as a Treatment for High Myopia in Children and Its Therapeutic Effect. BioMed Research International. 2019. Vol. 2019, no. 2019, pp.1-7.
https://search.emarefa.net/detail/BIM-1125872
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1125872